Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Hot flashes may return after ending Lexapro antidepressant: study
Reuters
Friday, November 30, 2012 - 10:34am
tags:
Lexapro, hot flashes, antidepressants, Forest Labs
J&J CEO Gorsky elected chairman, replacing Weldon
Reuters
Friday, November 30, 2012 - 9:41am
tags:
JNJ, Pharma CEOs, William Weldon, Alex Gorsky
FDA Rejection. EU Withdrawal. Set and Match?
Motley Fool
Friday, November 30, 2012 - 9:39am
tags:
FDA, Europe, ridaforolimus, Ariad Pharma, Merck
Exelixis Wins First Approval of Cancer Drug
Minyanville
Friday, November 30, 2012 - 9:37am
tags:
medullary thyroid cancer, Exelixis, Cometriq
Lpath's Q3 Filing Shines The Way For A Catalyst Filled 2013
Seeking Alpha
Friday, November 30, 2012 - 9:34am
tags:
Lpath, Pfizer, iSONEP
InterMune Gearing Up For Another Round With The FDA
Yahoo/Reuters
Thursday, November 29, 2012 - 12:03pm
tags:
InterMune, FDA, IPF, idiopathic pulmonary fibrosis, pirfenidone
Arena Opening New Doors
Seeking Alpha
Thursday, November 29, 2012 - 12:01pm
tags:
Arena Pharmaceuticals, IIdong Pharmaceuticals, Temanogrel, South Korea
Orphan Drug Status Potentially Huge For DARA Bio
Seeking Alpha
Thursday, November 29, 2012 - 11:58am
tags:
DARA Biosciences, orphan drugs, KRN5500, chronic chemotherapy-induced peripheral neuropathy
Revlimid Ramp-Up, New Drug Launches Make Celgene a Buy
Motley Fool
Thursday, November 29, 2012 - 11:05am
tags:
Revlimid, Celgene, Vidaza, Abraxane, apremilast, pomalidomide
J&J says won't enforce AIDS drug patent in Africa
Reuters
Thursday, November 29, 2012 - 11:04am
tags:
AIDS, JNJ, Africa, patents, Prezista
Merck in talks to buy Micro Labs
Financial Express, India
Thursday, November 29, 2012 - 10:43am
tags:
Micro Labs, Merck, M&A, India
Amarin Is Really Good At Delays, Drug Launches Not So Much
TheStreet.com
Thursday, November 29, 2012 - 10:42am
tags:
Amarin, Vascepa, drug launches, Celgene, Sanofi
Anthera Pharmaceuticals Trading Higher On Additional Data; Need For Capital Could Cap Upside
Seeking Alpha
Thursday, November 29, 2012 - 10:41am
tags:
Anthera, lupus, blisibimod
Merck withdraws Marketing Authorisation Application for ridaforolimus in Europe
The Fly on the Wall
Thursday, November 29, 2012 - 10:40am
tags:
Europe, ridaforolimus, Merck
S.Africa awards $667 mln HIV drugs supply contract
Reuters
Thursday, November 29, 2012 - 10:40am
tags:
HIV, South Africa, Abbott Labs, Adcock Ingram, Aspen Pharmacare
The 3 Biggest Risks Facing AstraZeneca
Motley Fool
Thursday, November 29, 2012 - 10:38am
tags:
AstraZeneca
FDA advisory panel backs J&J TB drug
Reuters
Thursday, November 29, 2012 - 10:38am
tags:
JNJ, FDA, advisory panels, tuberculosis, bedaquiline
Cialis Shows Promise in Rare Muscle Disease
WSJ Online
Thursday, November 29, 2012 - 10:36am
tags:
Cialis, Eli Lilly, Duchenne Muscular Dystrophy
Idenix Gets a Big Buy Rec
Motley Fool
Thursday, November 29, 2012 - 10:36am
tags:
Idenix
Abbott board paves way for split of company
Reuters
Thursday, November 29, 2012 - 10:35am
tags:
Abbott, AbbVie

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.